Binding affinity determination of therapeutic antibodies to membrane protein targets: Kinetic Exclusion Assay using cellular membranes for anti-CD20 antibody-Reference-Cited by-同舟云学术

Binding affinity determination of therapeutic antibodies to membrane protein targets: Kinetic Exclusion Assay using cellular membranes for anti-CD20 antibody

Published:2020-11 Issue: Volume:609 Page:113974
ISSN:0003-2697
Container-title:Analytical Biochemistry
language:en
Short-container-title:Analytical Biochemistry

Author:

Vaish Amit,Lin Joanne S.,McBride Helen J.,Grandsard Peter J.,Chen Qing

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference26 articles.

1. Research and development of next generation of antibody-based therapeutics;Li;Acta Pharmacol. Sin.,2010

2. Generation and characterization of fully human monoclonal antibodies against human Orai 1 for autoimmune disease;Lin;J. Pharmacol. Exp. Therapeut.,2013

3. Differential pathway coupling of the activated insulin receptor drives signaling selectivity by XMetA, an allosteric partial agonist antibody;Bedinger;J. Pharmacol. Exp. Therapeut.,2015

4. Therapeutic antibody targeting tumor- and osteoblastic niche-derived Jagged 1 sensitizes bone metastasis to chemotherapy;Zheng;Canc. Cell,2017

5. Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL;Kostenuik;J. Bone Miner. Res. : the official journal of the American Society for Bone and Mineral Research,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early determination of potential critical quality attributes of therapeutic antibodies in developability studies through surface plasmon resonance-based relative binding activity assessment;mAbs;2024-07-02

2. Kinetic exclusion assay using cellular membranes for affinity determination of anti-CD20 antibody;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

3. A novel, label‐free, pre‐equilibrium assay to determine the association and dissociation rate constants of therapeutic antibodies on living cells;British Journal of Pharmacology;2023-11-05

4. KD determination from time-resolved experiments on live cells with LigandTracer and reconciliation with end-point flow cytometry measurements;European Biophysics Journal;2021-07-24